Literature DB >> 29091867

LncRNATCF7 promotes the growth and self-renewal of glioma cells via suppressing the miR-200c-EpCAM axis.

Jian Zhao1, Lianglong Zhang2, Lizhi Zheng2, Youbo Hong2, Lizhi Zhao2.   

Abstract

Accumulating evidence has demonstrated that long non-coding RNAs (lncRNAs) are involved in tumor initiation and development. Recent studies illustrated that lncRNATCF7 was highly expressed in lung cancer and liver cancer, however, the expression pattern and function of lncRNATCF7 in glioma remains to be elucidated. Here, we found that lncTCF7 was highly expressed in glioma tissues and cell lines. Overexpression of lncTCF7 promoted the proliferation and migration of glioma cells. Down-regulation of lncTCF7 significantly suppressed the tumorigenesis of glioma. Mechanistically, lncTCF7 enhanced the self-renewal of glioma cells via up-regulating the expression of epithelial cell adhesion molecule (EpCAM). The detailed molecular mechanism uncovered that lncTCF7 bound to miR-200c and decreased the abundance of miR-200c, which consequently attenuated the negative regulation of miR-200c on EpCAM. Collectively, these data provide evidence to demonstrate the critical role of lncTCF7 in the tumorigeneis of glioma, which suggested that lncTCF7 might be a promising target in the treatment of glioma.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cell growth; EpCAM; Glioma; lncRNATCF7; miR-200c

Mesh:

Substances:

Year:  2017        PMID: 29091867     DOI: 10.1016/j.biopha.2017.10.039

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  Low LINC00599 expression is a poor prognostic factor in glioma.

Authors:  Qiang Fu; Shaoshan Li; Qingjiu Zhou; Kugeluke Yalikun; Dilimulati Yisireyili; Ming Xia
Journal:  Biosci Rep       Date:  2019-04-02       Impact factor: 3.840

2.  Identifying Structural Domains and Conserved Regions in the Long Non-Coding RNA lncTCF7.

Authors:  Michael C Owens; Sean C Clark; Allison Yankey; Srinivas Somarowthu
Journal:  Int J Mol Sci       Date:  2019-09-26       Impact factor: 5.923

3.  LncRNA RP11-422N16.3 Inhibits Cell Proliferation and EMT, and Induces Apoptosis in Hepatocellular Carcinoma Cells by Sponging miR-23b-3p.

Authors:  Yunpeng Sun; Qingqing Zhou; Junjian Li; Chang Zhao; Zhengping Yu; Qiandong Zhu
Journal:  Onco Targets Ther       Date:  2019-12-12       Impact factor: 4.147

4.  Long non-coding RNA T-cell factor 7 in multiple myeloma: A potential biomarker for deteriorated clinical features and poor prognosis.

Authors:  Cui Zhang; Min Chu; Yingchao Fan; Liting Wu; Zhumeng Li; Xiaoyan Ma; Wenfang Zhuang
Journal:  J Clin Lab Anal       Date:  2020-06-23       Impact factor: 2.352

5.  Long non-coding RNA T cell factor 7 is associated with increased disease risk and poor prognosis, and promotes cell proliferation, attenuates cell apoptosis and miR-200c expression in multiple myeloma.

Authors:  Tianling Ding; Ruoyu Deng; Ting Huang
Journal:  Oncol Lett       Date:  2020-12-18       Impact factor: 2.967

Review 6.  Regulation of the Cancer Stem Phenotype by Long Non-Coding RNAs.

Authors:  Jose Adan Gutierrez-Cruz; Vilma Maldonado; Jorge Melendez-Zajgla
Journal:  Cells       Date:  2022-07-30       Impact factor: 7.666

Review 7.  The miR-200 family: multiple effects on gliomas.

Authors:  Lilei Peng; Jie Fu; Yang Ming
Journal:  Cancer Manag Res       Date:  2018-07-13       Impact factor: 3.989

8.  Upregulated long non‑coding RNA LincIN promotes tumor progression via the regulation of nuclear factor 90/microRNA‑7/HOXB13 in esophageal squamous cell carcinoma.

Authors:  Zhibo Tan; Peitao Zhou; Zhenru Zhu; Ying Wang; Zeqin Guo; Mengying Shen; Yazhi Xiao; Weixi Shen; Dehua Wu
Journal:  Int J Mol Med       Date:  2021-03-11       Impact factor: 4.101

9.  Differential Expression of Decorin in Metastasising Colorectal Carcinoma Is Regulated by miR-200c and Long Non-Coding RNAs.

Authors:  Margareta Žlajpah; Kristian Urh; Jan Grosek; Nina Zidar; Emanuela Boštjančič
Journal:  Biomedicines       Date:  2022-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.